- Home
- WINT vs NIVF Comparison
WINT vs NIVF Comparison
Compare WINT & NIVF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WINT
- NIVF
- Stock Information
- Founded
- WINT 1992
- NIVF 2011
- Country
- WINT United States
- NIVF Thailand
- Employees
- WINT N/A
- NIVF N/A
- Industry
- WINT Biotechnology: Biological Products (No Diagnostic Substances)
- NIVF
- Sector
- WINT Health Care
- NIVF
- Exchange
- WINT Nasdaq
- NIVF NYSE
- Market Cap
- WINT 2.2M
- NIVF 2.1M
- IPO Year
- WINT 1995
- NIVF N/A
- Fundamental
- Price
- WINT $0.43
- NIVF $1.05
- Analyst Decision
- WINT Hold
- NIVF
- Analyst Count
- WINT 1
- NIVF 0
- Target Price
- WINT $350.00
- NIVF N/A
- AVG Volume (30 Days)
- WINT 7.1M
- NIVF 9.1M
- Earning Date
- WINT 08-18-2025
- NIVF 01-01-0001
- Dividend Yield
- WINT N/A
- NIVF N/A
- EPS Growth
- WINT N/A
- NIVF N/A
- EPS
- WINT N/A
- NIVF N/A
- Revenue
- WINT N/A
- NIVF $5,433,375.00
- Revenue This Year
- WINT N/A
- NIVF N/A
- Revenue Next Year
- WINT N/A
- NIVF N/A
- P/E Ratio
- WINT N/A
- NIVF N/A
- Revenue Growth
- WINT N/A
- NIVF 5.79
- 52 Week Low
- WINT $0.36
- NIVF $1.00
- 52 Week High
- WINT $737.44
- NIVF $656.00
- Technical
- Relative Strength Index (RSI)
- WINT 35.91
- NIVF 33.99
- Support Level
- WINT $0.52
- NIVF $1.00
- Resistance Level
- WINT $0.64
- NIVF $6.13
- Average True Range (ATR)
- WINT 0.09
- NIVF 0.17
- MACD
- WINT -0.00
- NIVF -0.01
- Stochastic Oscillator
- WINT 14.12
- NIVF 9.35
About WINT Windtree Therapeutics Inc.
Windtree Therapeutics Inc is a biotechnology company focused on advancing early and late-stage therapies for critical conditions and diseases. Its portfolio of product candidates includes istaroxime, a Phase 2 candidate with sarco endoplasmic reticulum Ca2+ -ATPase 2a, or SERCA2a, activating properties for acute heart failure and associated cardiogenic shock, preclinical SERCA2a activators for heart failure, rostafuroxin for the treatment of hypertension in patients with a specific genetic profile, and a preclinical atypical protein kinase C iota, or aPKCi, inhibitor, being developed for potential application in rare and broad oncology indications. It operates in one operating segment, which is the research and development of products focused on cardiovascular disease.
About NIVF NEWGENIVF GROUP LIMITED
NewGenIvf Group Ltd is a company engaged in providing assisted reproductive services in Asia Pacific with a focus on providing fertility treatments to fulfil the dreams of building families, NewGenIvf mainly offers two services, namely first which is a in-vitro fertilization (IVF) treatment service, comprising traditional IVF and egg donation; and surrogacy and ancillary caring services.